Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.

Mannion, Aarren J; Odell, Adam F; Baker, Syed Murtuza; Matthews, Laura C; Jones, Pamela F; Cook, Graham P

Mannion, Aarren J; Odell, Adam F; Baker, Syed Murtuza; Matthews, Laura C; Jones, Pamela F; Cook, Graham P.

Afiliación

Mannion AJ; Leeds Institute of Medical Research, University of Leeds School of Medicine, St. James's University Hospital, Leeds, United Kingdom.
Odell AF; Leeds Institute of Medical Research, University of Leeds School of Medicine, St. James's University Hospital, Leeds, United Kingdom.
Baker SM; Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Matthews LC; Leeds Institute of Medical Research, University of Leeds School of Medicine, St. James's University Hospital, Leeds, United Kingdom.
Jones PF; Leeds Institute of Medical Research, University of Leeds School of Medicine, St. James's University Hospital, Leeds, United Kingdom.
Cook GP; Leeds Institute of Medical Research, University of Leeds School of Medicine, St. James's University Hospital, Leeds, United Kingdom.

Front Cell Dev Biol ; 11: 1129015, 2023.

Article en En | MEDLINE | ID: mdl-37138793

Palabras clave

CD146; MCAM; breast cancer; cancer heterogeneity; epithelial mesenchymal transition (EMT); metastasis; transendothelial migration (TEM); tumour plasticity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Dev Biol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google